125 related articles for article (PubMed ID: 7605198)
21. Detection of latent cytomegalovirus DNA in diverse organs of mice.
Collins T; Pomeroy C; Jordan MC
J Infect Dis; 1993 Sep; 168(3):725-9. PubMed ID: 8394863
[TBL] [Abstract][Full Text] [Related]
22. The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection.
Balthesen M; Dreher L; Lucin P; Reddehase MJ
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2329-36. PubMed ID: 8077931
[TBL] [Abstract][Full Text] [Related]
23. Single cell detection of latent cytomegalovirus reactivation in host tissue.
Marquardt A; Halle S; Seckert CK; Lemmermann NAW; Veres TZ; Braun A; Maus UA; Förster R; Reddehase MJ; Messerle M; Busche A
J Gen Virol; 2011 Jun; 92(Pt 6):1279-1291. PubMed ID: 21325477
[TBL] [Abstract][Full Text] [Related]
24. Focal transcriptional activity of murine cytomegalovirus during latency in the lungs.
Kurz SK; Rapp M; Steffens HP; Grzimek NK; Schmalz S; Reddehase MJ
J Virol; 1999 Jan; 73(1):482-94. PubMed ID: 9847354
[TBL] [Abstract][Full Text] [Related]
25. Latent murine cytomegalovirus infection in macrophages.
Pollock JL; Presti RM; Paetzold S; Virgin HW
Virology; 1997 Jan; 227(1):168-79. PubMed ID: 9007070
[TBL] [Abstract][Full Text] [Related]
26. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
Morello CS; Cranmer LD; Spector DH
J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
[TBL] [Abstract][Full Text] [Related]
27. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice.
Yuhasz SA; Dissette VB; Cook ML; Stevens JG
Virology; 1994 Jul; 202(1):272-80. PubMed ID: 8009839
[TBL] [Abstract][Full Text] [Related]
28. Development of a highly sensitive quantitative competitive PCR assay for the detection of murine cytomegalovirus DNA.
Palmon A; Tel-or S; Shai E; Rager-Zisman B; Burstein Y
J Virol Methods; 2000 May; 86(2):107-14. PubMed ID: 10785285
[TBL] [Abstract][Full Text] [Related]
29. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease.
Reddehase MJ; Balthesen M; Rapp M; Jonjić S; Pavić I; Koszinowski UH
J Exp Med; 1994 Jan; 179(1):185-93. PubMed ID: 8270864
[TBL] [Abstract][Full Text] [Related]
30. Immunosuppression is not required for reactivation of latent murine cytomegalovirus.
Koffron A; Varghese T; Hummel M; Yan S; Kaufman D; Fryer J; Leventhal J; Stuart F; Abecassis M
Transplant Proc; 1999; 31(1-2):1395-6. PubMed ID: 10083617
[TBL] [Abstract][Full Text] [Related]
31. Expression of a murine cytomegalovirus early-late protein in "latently" infected mice.
Yu Y; Henry SC; Xu F; Hamilton JD
J Infect Dis; 1995 Aug; 172(2):371-9. PubMed ID: 7622880
[TBL] [Abstract][Full Text] [Related]
32. Concurrent murine cytomegalovirus and Klebsiella pneumoniae infections in germfree mice.
Tazume S; Umehara K; Leung WC; Ando K; Hata J; Hashimoto K
Tokai J Exp Clin Med; 1990 Mar; 15(1):87-92. PubMed ID: 1965065
[TBL] [Abstract][Full Text] [Related]
33. Murine cytomegalovirus DNA in peripheral blood of latently infected mice is detectable only in monocytes and polymorphonuclear leukocytes.
Mitchell BM; Leung A; Stevens JG
Virology; 1996 Sep; 223(1):198-207. PubMed ID: 8806553
[TBL] [Abstract][Full Text] [Related]
34. Detection of murine cytomegalovirus (MCMV) DNA in skin using the polymerase chain reaction (PCR).
Abecassis MM; Jiang X; O'Neil ME; Bale JF
Microb Pathog; 1993 Jul; 15(1):17-22. PubMed ID: 8412624
[TBL] [Abstract][Full Text] [Related]
35. Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
Keil SD; Saakadze N; Bowen R; Newman JL; Karatela S; Gordy P; Marschner S; Roback J; Hillyer CD
Transfusion; 2015 Apr; 55(4):858-63. PubMed ID: 25438832
[TBL] [Abstract][Full Text] [Related]
36. Intraocular viral replication after systemic murine cytomegalovirus infection requires immunosuppression.
Gao EK; Yu XH; Lin CP; Zhang H; Kaplan HJ
Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2322-7. PubMed ID: 7558728
[TBL] [Abstract][Full Text] [Related]
37. Heart Dysfunction Following Long-Term Murine Cytomegalovirus Infection: Fibrosis, Hypertrophy, and Tachycardia.
Bonavita CM; White TM; Francis J; Cardin RD
Viral Immunol; 2020 Apr; 33(3):237-245. PubMed ID: 32286167
[TBL] [Abstract][Full Text] [Related]
38. Improved detection and quantification of mouse cytomegalovirus by real-time PCR.
Vliegen I; Herngreen S; Grauls G; Bruggeman C; Stassen F
Virus Res; 2003 Dec; 98(1):17-25. PubMed ID: 14609626
[TBL] [Abstract][Full Text] [Related]
39. In vivo disturbance of hematopoiesis in mice persistently infected with murine cytomegalovirus: impairment of stromal cell function.
Mori T; Nakamura M; Shimizu K; Ikeda Y; Ando K
Virology; 1999 Jan; 253(2):145-54. PubMed ID: 9918873
[TBL] [Abstract][Full Text] [Related]
40. Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection.
Henry SC; Schmader K; Brown TT; Miller SE; Howell DN; Daley GG; Hamilton JD
J Virol Methods; 2000 Sep; 89(1-2):61-73. PubMed ID: 10996640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
